Switch View
© Globe Newswire
31.10.2025
ISIN: IL0006290147
Teva Pharmaceutical Industries Ltd
TEVA
LISTED
TLV
Teva to Present at UBS Global Healthcare Conference and Jefferies London Healthcare Conference in November
News Preview
TEL AVIV, Israel, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Richard Francis, Teva's President and CEO, will present at two upcoming investor conferences in November as follows:...
Themefolio
Profiler
Peergroup
© Globe Newswire
31.10.2025
ISIN: US64131A1051
Neuronetics Inc
STIM
LISTED
NASDAQ
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
News Preview
MALVERN, Pa., Oct. 31, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, today announced the granting of inducement awards to twelve new employees as d...
Themefolio
Profiler
Peergroup
© Globe Newswire
31.10.2025
ISIN: US31573L1052
FibroBiologics Inc.
FBLG
LISTED
NASDAQ
FibroBiologics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
News Preview
Advancing preparations to begin manufacturing of fibroblast-based spheroids product candidate, CYWC628, for the Phase 1/2 clinical trial evaluating CYWC628 in diabetic foot ulcers (DFU) patients ...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Leerverkaufsstatistiken, Hedge-Fund Aktivitäten und viele weitere nutzerwertige Informationen benutzerfreundlich aufbereitet
© PR Newswire
31.10.2025
ISIN: US1266501006
CVS Health Corp
CVS
LISTED
NYSE
CVS Health Boosts CVS Pharmacy Customer Generosity to Address Food Insecurity
News Preview
WOONSOCKET, R.I., Oct. 31, 2025 /PRNewswire/ -- CVS Pharmacy® customers donated more than $3 million this year to support local food banks across the country, and CVS Health® (NYSE: CVS) is boosting the overall contribution to support Feeding America. The in-store campaign, hosted at CVS Pharmacy locations nation...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© Globe Newswire
31.10.2025
ISIN: US68621F1021
Organogenesis Holdings Inc
ORGO
LISTED
NASDAQ
Organogenesis Holdings Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News Preview
CANTON, Mass., Oct. 31, 2025 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (the “Company”) (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today announced that effective October 29,...
Themefolio
Profiler
Peergroup
© Globe Newswire
31.10.2025
ISIN: US18914F1030
Clover Health Investments Corp
CLOV
LISTED
NASDAQ
Clover Health Announces Chelsea Clinton to Step Down from Board Following Eight Years of Service
News Preview
WILMINGTON, Del., Oct. 31, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”) today announced that Chelsea Clinton, the longest-serving member of its Board of Directors, having joined the Board in early 2017, will conclude her service as of October 31, 2025....
Themefolio
Profiler
Peergroup
© BusinessWire
31.10.2025
ISIN: US05352A1007
Avantor Inc
AVTR
LISTED
NYSE
Rosen Law Firm Urges Avantor, Inc. (NYSE: AVTR) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights
News Preview
Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action lawsuit on behalf of purchasers and acquirers of Avantor, Inc. (NYSE: AVTR) common stock between March 5, 2024 and October 28, 2025, both dates inclusive (the “Class Period”). Avantor provides scientific products and services for customers in vario...
Themefolio
Profiler
Peergroup
© PR Newswire
31.10.2025
ISIN: GB00B2425G68
Craneware PLC
CRW
LISTED
AIMX
The Craneware Group Hosts 340B Rebate Forum, Confirms No New Vendor Needed for Pilot
News Preview
With HRSA's approval of eight manufacturer rebate plans, hospitals enter the 60-day readiness period before the January 1, 2026, launch.
DEERFIELD BEACH, Fla., Oct. 31, 2025 /PRNewswire/ -- The Craneware Group convened leaders from 25 major U.S. health systems,...
Themefolio
Profiler
Peergroup
© BusinessWire
31.10.2025
ISIN: US05352A1007
Avantor Inc
AVTR
LISTED
NYSE
Securities Fraud Investigation Into Avantor, Inc. (AVTR) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
News Preview
The Law Offices of Frank R. Cruz announces an investigation of Avantor, Inc. (“Avantor” or the “Company”) (NYSE: AVTR) on behalf of investors concerning the Company’s possible violations of federal securities laws.
IF YOU ARE AN INVESTOR WHO LOST MONEY ON AVANTOR, INC. (AVTR), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER Y...
Themefolio
Profiler
Peergroup
© BusinessWire
31.10.2025
ISIN: FR0012432516
Poxel SA
POXEL
LISTED
EURONEXT
Appointment of Yves Decadt as Member of Poxel’s Board of Directors
News Preview
Regulatory News:
POXEL SA (Euronext : POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including metabolic dysfunction-associated steatohepatitis (MASH) and rare metabolic disorders, today announces the appointment of Yves Decadt as a m...
Themefolio
Profiler
Peergroup
© Globe Newswire
31.10.2025
ISIN: BE0003874915
Fagron NV
FAGR
LISTED
EURONEXT
Fagron’s share buy-back program: Weekly update
News Preview
Regulated informationNazareth (Belgium)/Rotterdam (The Netherlands), 31 October 2025 – 6PM CET...
Themefolio
Profiler
Peergroup
© BusinessWire
31.10.2025
ISIN: US2521311074
Dexcom Inc
DXCM
LISTED
NASDAQ
DXCM Investor Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline in Securities Fraud Class Action Lawsuit Filed Against DexCom, Inc.
News Preview
The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against DexCom, Inc. (“DexCom”) (NASDAQ: DXCM) on behalf of those who purchased or otherwise acquired DexCom securities between July 26, 2024, and September 17, 2025, inclusive (the “Class Period”). The lead...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© BusinessWire
31.10.2025
ISIN: US8523123052
STAAR Surgical Co
STAA
LISTED
NASDAQ
Yunqi Capital Issues Letter to STAAR Surgical Board Calling for Termination of the Proposed Merger with Alcon
News Preview
Yunqi Capital Limited (together with its affiliates and the funds it advises, “Yunqi Capital”), an investment management firm and 5.1% shareholder of STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ:STAA), today released the following letter to the Board of Directors of STAAR after its decision to postpone STAAR’s Special Meeting of Stock...
Themefolio
Profiler
Peergroup
© PR Newswire
31.10.2025
ISIN: US2521311074
Dexcom Inc
DXCM
LISTED
NASDAQ
DXCM INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that DexCom, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
News Preview
NEW YORK, Oct. 31, 2025 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against DexCom, Inc. ("DexCom" or "the Company") (NASDAQ: DXCM) and certain of its officers....
Themefolio
Profiler
Peergroup
© PR Newswire
31.10.2025
ISIN: US60855R1005
Molina Healthcare Inc
MOH
LISTED
NYSE
Molina Healthcare, Inc. (MOH) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
News Preview
LOS ANGELES, Oct. 31, 2025 /PRNewswire/ -- Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Molina Healthcare, Inc. ("Molina" or the "Company") (NYSE: MOH)....
Themefolio
Profiler
Peergroup
© PR Newswire
31.10.2025
ISIN: US23282W6057
Cytokinetics Inc
CYTK
LISTED
NASDAQ
Cytokinetics, Incorporated (CYTK) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
News Preview
BENSALEM, Pa., Oct. 31, 2025 /PRNewswire/ -- The Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Cytokinetics, Incorporated ("Cytokinetics" or the "Company") (NASDAQ: CYTK)....
Themefolio
Profiler
Peergroup
© BusinessWire
31.10.2025
ISIN: US45257U1088
Immunome Inc
IMNM
LISTED
NASDAQ
Immunome to Present at 2nd Annual Guggenheim Healthcare Innovation Conference
News Preview
Immunome, Inc. (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, today announced that Immunome management will present at the 2nd Annual Guggenheim Healthcare Innovation Conference on Tuesday, Nov. 11, 2025 at 8:30 a.m. ET.
Interested parties can access the live audio webcas...
Themefolio
Profiler
Peergroup
© BusinessWire
31.10.2025
ISIN: US2053061030
TruBridge Inc
TBRG
LISTED
NASDAQ
TruBridge Announces Third Quarter 2025 Conference Call to Be Held Friday, November 7, 2025
News Preview
TruBridge, Inc. (NASDAQ: TBRG), a leading provider of revenue cycle management and healthcare technology solutions for rural and community healthcare organizations, today announced that it will release its financial results for the third quarter ended September 30, 2025, on Thursday, November 6, 2025, after the market closes. The Company will host...
Themefolio
Profiler
Peergroup
© BusinessWire
31.10.2025
ISIN: FR0014000MR3
Eurofins Scientific SE
ERF
LISTED
EURONEXT
Eurofins Scientific: Director/PDMR Shareholding
News Preview
Eurofins Scientific SE (EUFI.PA) (Paris:ERF) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Dealing Form for each PDMR can be found below.
This notification is made in accordance with the European Market Abuse Regulation.
NOTIFICATION AND PUBLIC DISCLOSURE OF T...
Themefolio
Profiler
Peergroup
© PR Newswire
31.10.2025
ISIN: US15135B1017
Centene Corp
CNC
LISTED
NYSE
Ambetter Health Kicks Off Marketplace Open Enrollment
News Preview
With 5.8 million members across 29 states, Ambetter Health continues its legacy of delivering affordable, accessible coverage through Centene Corporation's national network.
ST. LOUIS, Oct. 31, 2025 /PRNewswire/ -- As the Marketplace open enrollment begins, Ambe...
Themefolio
Profiler
Peergroup
© Globe Newswire
31.10.2025
ISIN: DK0015998017
Bavarian Nordic A/S
BAVA
LISTED
CPH
Bavarian Nordic Announces Major Shareholder Notification from Morgan Stanley
News Preview
COPENHAGEN, Denmark, October 31, 2025 – Pursuant to section 30 of the Danish Capital Markets Act, Bavarian Nordic A/S hereby announces that the Company has received notification from Morgan Stanley that they hold 4.99% of the shares and voting rights in Bavarian Nordic A/S as of October 27, 2025....
Themefolio
Profiler
Peergroup
© PR Newswire
31.10.2025
ISIN: US0311621009
Amgen Inc
AMGN
LISTED
NASDAQ
AMGEN'S LANDMARK PHASE 3 REPATHA DATA TO BE PRESENTED AS LATE BREAKER AT THE AMERICAN HEART ASSOCIATION SCIENTIFIC SESSIONS 2025
News Preview
Repatha VESALIUS-CV Trial Met Dual Primary Endpoints Demonstrating Reduction in CV Events in High-Risk Patients Who Have Never Had a Heart Attack or Stroke
Real-World Evidence from the Repatha-CE Trial Reinforces Its Position as a Leading LDL-C Lowering Therapy...
Themefolio
Profiler
Peergroup
© PR Newswire
31.10.2025
ISIN: US1897631057
Co-Diagnostics Inc
CODX
LISTED
NASDAQ
Co-Diagnostics, Inc. Announces Third Quarter 2025 Earnings Release Date and Webcast
News Preview
SALT LAKE CITY, Oct. 31, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today it will release its third quarter 2025 financial results on Thursday, November 13, 2025, after the...
Themefolio
Profiler
Peergroup
© PR Newswire
31.10.2025
ISIN: US23282W6057
Cytokinetics Inc
CYTK
LISTED
NASDAQ
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of November 17, 2025 in Cytokinetics, Incorporated Lawsuit - CYTK
News Preview
NEW YORK, Oct. 31, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Cytokinetics, Incorporated ("Cytokinetics" or the "Company") (NASDAQ: CYTK) of a class action securities lawsuit....
Themefolio
Profiler
Peergroup
© PR Newswire
31.10.2025
ISIN: KY61559X1045
MoonLake Immunotherapeutics
MLTX
LISTED
NASDAQ
Shareholders that lost money on MoonLake Immunotherapeutics(MLTX) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More
News Preview
NEW YORK, Oct. 31, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in MoonLake Immunotherapeutics ("MoonLake" or the "Company") (NASDAQ: MLTX) of a class action securities lawsuit....
Themefolio
Profiler
Peergroup
© PR Newswire
31.10.2025
ISIN: US0718131099
Baxter International, Inc.
BAX
LISTED
NYSE
Investors who lost money on Baxter International, Inc.(BAX) should contact Levi & Korsinsky about pending Class Action - BAX
News Preview
NEW YORK, Oct. 31, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Baxter International, Inc. ("Baxter International, Inc." or the "Company") (NYSE: BAX) of a class action securities lawsuit....
Themefolio
Profiler
Peergroup
© PR Newswire
31.10.2025
ISIN: US0021202025
Atyr Pharma, Inc.
ATYR
LISTED
NASDAQ
Shareholders that lost money on aTyr Pharma, Inc.(ATYR) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More
News Preview
NEW YORK, Oct. 31, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in aTyr Pharma, Inc. ("aTyr" or the "Company") (NASDAQ: ATYR) of a class action securities lawsuit....
Themefolio
Profiler
Peergroup
© PR Newswire
31.10.2025
ISIN: US8051111016
Savara Inc
SVRA
LISTED
NASDAQ
Levi & Korsinsky Reminds Savara Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of November 7, 2025 - SVRA
News Preview
NEW YORK, Oct. 31, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Savara Inc. ("Savara Inc." or the "Company") (NASDAQ: SVRA) of a class action securities lawsuit....
Themefolio
Profiler
Peergroup
© PR Newswire
31.10.2025
ISIN: US5165441032
Lantheus Holdings Inc
LNTH
LISTED
NASDAQ
Shareholders that lost money on Lantheus Holdings, Inc.(LNTH) should contact Levi & Korsinsky about pending Class Action - LNTH
News Preview
NEW YORK, Oct. 31, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Lantheus Holdings, Inc. ("Lantheus" or the "Company") (NASDAQ: LNTH) of a class action securities lawsuit....
Themefolio
Profiler
Peergroup
© BusinessWire
31.10.2025
ISIN: CA94947L1022
WELL Health Technologies Corp
WELL
LISTED
TSX
WELL Subsidiary WELLSTAR Technologies Announces $62M Financing to Support Its Pre-Spinout Growth Strategy
News Preview
Not for distribution to U.S. news wire services or dissemination in the United States
WELL Health Technologies Corp. (TSX: WELL, OTCQX: WHTCF) (“WELL”), a digital healthcare company focused on improving health outcomes by leveraging technology to empower healthcare practitioners and their patients globally, is pleased to announce its majority-ow...
Themefolio
Profiler
Peergroup
© Globe Newswire
31.10.2025
ISIN: US14070B3096
Capricor Therapeutics, Inc.
CAPR
LISTED
NASDAQ
Capricor Therapeutics to Present Third Quarter 2025 Financial Results and Recent Corporate Update on November 10
News Preview
Company to Host Conference Call on November 10, 2025, at 4:30 p.m. ET Company to Host Conference Call on November 10, 2025, at 4:30 p.m. ET...
Themefolio
Profiler
Peergroup
© Globe Newswire
31.10.2025
ISIN: DK0015998017
Bavarian Nordic A/S
BAVA
LISTED
CPH
Bavarian Nordic shareholders are reminded of expiry of the offer period regarding the takeover offer from consortium consisting of Nordic Capital and Permira
News Preview
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION...
Themefolio
Profiler
Peergroup
© Globe Newswire
31.10.2025
ISIN: US62855J1043
Myriad Genetics Inc
MYGN
LISTED
NASDAQ
New Post-Hoc Analysis Shows Patients Whose Clinicians Had Access to GeneSight Results for Depression Treatment Are More Likely to Feel Better Sooner
News Preview
Faster initial remission and response, persistent benefit over six months Faster initial remission and response, persistent benefit over six months...
Themefolio
Profiler
Peergroup
© BusinessWire
31.10.2025
ISIN: US73245B1070
SBC Medical Group Holdings, Inc.
SBC
LISTED
NASDAQ
SBC Medical to Announce Q3 2025 Financial Results on November 14 and Hold Earnings Call on November 17
News Preview
SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical” or the “Company”), a global provider of comprehensive consulting and management services to the medical corporations and their clinics, today announced that it will release its Q3 2025 financial results on Friday, November 14, 2025, before the U.S. market opens.
The Company wil...
Themefolio
Profiler
Peergroup
© BusinessWire
31.10.2025
ISIN: US3755581036
Gilead Sciences Inc
GILD
LISTED
NASDAQ
Gilead Sciences Wins Prestigious 2025 Prix Galien USA Award for Best Pharmaceutical Product With Yeztugo® (Lenacapavir)
News Preview
Gilead Sciences, Inc. (Nasdaq: GILD) today announced it has been awarded the prestigious 2025 Prix Galien USA Award for Best Pharmaceutical Product for Yeztugo® (lenacapavir), the company’s twice-yearly injectable HIV-1 capsid inhibitor that provides adults and adolescents (≥35kg) at risk of HIV-1 acquisition with a new, highly effective option fo...
Themefolio
Profiler
Peergroup
© BusinessWire
31.10.2025
ISIN: US81728J1097
Sensus Healthcare, Inc.
SRTS
LISTED
NASDAQ
Sensus Healthcare Announces the Passing of Director Bill McCall
News Preview
Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological skin conditions, announces the passing of longtime friend of the Company and current Director William “Bill” McCall.
Bill’s involvement with Sensus d...
Themefolio
Profiler
Peergroup
© BusinessWire
31.10.2025
ISIN: US04635X1028
Astria Therapeutics Inc
ATXS
LISTED
NASDAQ
Astria Therapeutics to Present at Upcoming American College of Allergy, Asthma, and Immunology Annual Scientific Meeting
News Preview
Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, today announced that it will present final results from the ALPHA-STAR Phase 1b/2 trial of navenibart in people living with hereditary angioedema (HAE) at the American College of Allergy, Asthma,...
Themefolio
Profiler
Peergroup
© PR Newswire
31.10.2025
ISIN: US69366J2006
PTC Therapeutics Inc
PTCT
LISTED
NASDAQ
PTC Therapeutics to Participate at Upcoming Investor Conferences
News Preview
WARREN, N.J., Oct. 31, 2025 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that its executives will speak at the following conferences:...
Themefolio
Profiler
Peergroup
© PR Newswire
31.10.2025
ISIN: US00287Y1091
AbbVie Inc
ABBV
LISTED
EURONEXT
AbbVie Reports Third-Quarter 2025 Financial Results
News Preview
Reports Third-Quarter Diluted EPS of $0.10 on a GAAP Basis, a Decrease of 88.6 Percent; Adjusted Diluted EPS of $1.86, a Decrease of 38.0 Percent; These Results Include an Unfavorable Impact of $1.50 Per Share Related to Acquired IPR&D and Milestones Expense ...
Themefolio
Profiler
Peergroup
© BusinessWire
31.10.2025
ISIN: US98887Q1040
Zai Lab Limited
ZLAB
LISTED
NASDAQ
Zai Lab Announces Participation in Investor Conferences in November and December 2025
News Preview
Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that members of the Company’s senior management team will participate in the following investor conferences in November and December 2025:
Jefferies Global Healthcare Conference in London
Fireside Chat: Wednesday, November 19, 2025 at 8:30AM GMT
Location: London
Citi's 2025 Global Heal...
Themefolio
Profiler
Peergroup
© Globe Newswire
31.10.2025
ISIN: US21900C3088
CorMedix Inc
CRMD
LISTED
NASDAQ
CorMedix Inc. to Report Third Quarter 2025 Financial Results and Provide a Corporate Update on November 12, 2025
News Preview
BERKELEY HEIGHTS, N.J., Oct. 31, 2025 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, today announced that it will report its financial results for the third quarter ended September 30, 2025, before the market...
Themefolio
Profiler
Peergroup
© Globe Newswire
31.10.2025
ISIN: US2546041011
Disc Medicine Inc
IRON
LISTED
NASDAQ
Disc Medicine to Participate in Upcoming Investor Conferences
News Preview
WATERTOWN, Mass., Oct. 31, 2025 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, announced today that company management will participate in fireside chats at t...
Themefolio
Profiler
Peergroup
© BusinessWire
31.10.2025
ISIN: US86627T1088
Summit Therapeutics Inc
SMMT
LISTED
NASDAQ
Overall Survival Data from HARMONi-A, Featuring Ivonescimab in Combination with Chemotherapy vs. Chemotherapy in 2L+ Treatment of Patients with EGFRm NSCLC in China, to be Showcased at SITC 2025
News Preview
Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit,” “we,” or the “Company”) today announced that results from the Phase III HARMONi-A trial, conducted in China and sponsored by our partner, Akeso, Inc. (“Akeso,” HKEX Code: 9926.HK), featuring the novel, potential first-in-class investigational bispecific antibody, ivonescimab, will be presented as...
Themefolio
Profiler
Peergroup
© BusinessWire
31.10.2025
ISIN: US6323071042
Natera Inc
NTRA
LISTED
NASDAQ
Natera Announces Expansion to 20 Genes for its Fetal Focus™ Single-Gene NIPT
News Preview
Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA (cfDNA) and precision medicine, today announced it will expand its Fetal Focus test to cover 20 genes, marking a major advancement in single-gene noninvasive prenatal testing (sgNIPT). Building on the success of the initial Fetal Focus 5-gene test, launched in August, the new expanded p...
Themefolio
Profiler
Peergroup
© Globe Newswire
31.10.2025
ISIN: US15687V1098
Certara Inc
CERT
LISTED
NASDAQ
Certara to Participate in Upcoming Investor Conferences
News Preview
RADNOR, Pa., Oct. 31, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that Company management will participate in the following investor conferences:...
Themefolio
Profiler
Peergroup
© Globe Newswire
31.10.2025
ISIN: US43906K2096
HOOKIPA Pharma Inc
HOOK
LISTED
NASDAQ
HOOKIPA Pharma Announces Completion of Sale of HBV and HIV Assets to Gilead
News Preview
NEW YORK and VIENNA, Oct. 31, 2025 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (OTCID: HOOK, “HOOKIPA”) today announced the completion of the sale of its assets related to HOOKIPA’s HB-400 program and certain of its assets related to HOOKIPA’s HB-500 program to Gilead Sciences, Inc. (“Gilead”)....
Themefolio
Profiler
Peergroup
© BusinessWire
31.10.2025
ISIN: US1241551027
Butterfly Network Inc
BFLY
LISTED
NYSE
Butterfly Network Reports Third Quarter 2025 Financial Results
News Preview
Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly” or the “Company”), a digital health company transforming care with portable, semiconductor-based ultrasound technology and intuitive software, today announced financial results for the third quarter ended September 30, 2025, and provided a business update.
Joseph DeVivo, Butterfly's President, Ch...
Themefolio
Profiler
Peergroup
© Globe Newswire
31.10.2025
ISIN: US2210151005
Corvus Pharmaceuticals Inc
CRVS
LISTED
NASDAQ
Corvus Pharmaceuticals to Present at the Guggenheim 2nd Annual Healthcare Innovation Conference
News Preview
SOUTH SAN FRANCISCO, Calif., Oct. 31, 2025 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced that members of its leadership team will conduct one-on-one meetings with investors and participate in a fireside chat presentation at the Guggenheim 2nd Annual Healthcare Innovati...
Themefolio
Profiler
Peergroup
© Globe Newswire
31.10.2025
ISIN: US88322Q1085
TG Therapeutics Inc
TGTX
LISTED
NASDAQ
TG Therapeutics to Host Conference Call on Third Quarter 2025 Financial Results and Business Update
News Preview
Conference Call to be Held Monday, November 3, 2025, at 8:30 am ET Conference Call to be Held Monday, November 3, 2025, at 8:30 am ET...
Themefolio
Profiler
Peergroup
© Globe Newswire
31.10.2025
ISIN: US23282W6057
Cytokinetics Inc
CYTK
LISTED
NASDAQ
Cytokinetics Announces Upcoming Presentations at the Hypertrophic Cardiomyopathy Medical Society Scientific Sessions and American Heart Association Scientific Sessions 2025
News Preview
SOUTH SAN FRANCISCO, Calif., Oct. 31, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced upcoming presentations, including three Late Breaking Science presentations related to MAPLE-HCM (Metoprolol vs Aficamten in Patients with LVOT Obstruction on Exercise Capacity in HCM), at the Hypertrophic Cardiomyopathy Medica...
Themefolio
Profiler
Peergroup
© Globe Newswire
31.10.2025
ISIN: CA92767B1058
Vireo Growth Inc
VREO
LISTED
CSE
Vireo Growth Inc. to Release Third Quarter 2025 Results on November 12, 2025
News Preview
MINNEAPOLIS, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Vireo Growth Inc. ("Vireo" or the "Company") (CSE: VREO; OTCQX: VREOF), today announced that it will release its financial results for its third fiscal quarter ended September 30, 2025 on Wednesday, November 12, 2025, before the market opens....
Themefolio
Profiler
Peergroup
© Newsfile
31.10.2025
ISIN: CA41138T1057
Happy Belly Food Group Inc.
HBFG
LISTED
CSE
Happy Belly Food Group's Yolks Breakfast Signs Franchise Agreement for the City of Edmonton, Alberta
News Preview
Toronto, Ontario--(Newsfile Corp. - October 31, 2025) - Happy Belly Food Group Inc. (CSE: HBFG) (OTCQB: HBFGF) ("Happy Belly" or the "Company"), a leader in acquiring and scaling emerging food brands across Canada, is pleased to announce that Yolks Breakfast ("Yolks") has signed a new franchise agreement for the City of Edmonton with a franchisee w...
Themefolio
Profiler
Peergroup
© Globe Newswire
31.10.2025
ISIN: US03152W1099
Amicus Therapeutics Inc
FOLD
LISTED
NASDAQ
Amicus Therapeutics to Present at Upcoming Investor Conferences in November 2025
News Preview
PRINCETON, N.J., Oct. 31, 2025 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that management will participate in upcoming presentations at the following investor conferences in November....
Themefolio
Profiler
Peergroup
© Globe Newswire
31.10.2025
ISIN: US91678A1079
Upstream Bio, Inc.
UPB
LISTED
NASDAQ
Upstream Bio to Participate in Upcoming November Investor Conferences
News Preview
WALTHAM, Mass., Oct. 31, 2025 (GLOBE NEWSWIRE) -- Upstream Bio, Inc. (Nasdaq: UPB), a clinical-stage company developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders, today announced that Rand Sutherland, MD, Chief Executive Officer of Upstream Bio, will be participating in the following upcoming inve...
Themefolio
Profiler
Peergroup
© Globe Newswire
31.10.2025
ISIN: US75886F1075
Regeneron Pharmaceuticals Inc
REGN
LISTED
NASDAQ
Dupixent® (dupilumab) Wins Prestigious 2025 Prix Galien USA Best Biotechnology Product Award
News Preview
Award recognizes the groundbreaking science of Dupixent and its transformational impact on multiple rare and common allergic and atopic conditions ...
Themefolio
Profiler
Peergroup
© PR Newswire
31.10.2025
ISIN: US45166A1025
IDEAYA Biosciences Inc
IDYA
LISTED
NASDAQ
IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
News Preview
SOUTH SAN FRANCISCO, Calif., Oct. 31, 2025 /PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the discovery and development of targeted therapeutics, today announced that, on October 30, 2025, the Compensation Committee of IDEAYA's Board of Directors grante...
Themefolio
Profiler
Peergroup
© Globe Newswire
31.10.2025
ISIN: US0094961002
AirSculpt Technologies Inc
AIRS
LISTED
NASDAQ
AirSculpt Technologies Announces Third Quarter Fiscal 2025 Earnings Release Date and Conference Call
News Preview
MIAMI BEACH, Fla., Oct. 31, 2025 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (“AirSculpt”) (NASDAQ: AIRS) an industry leader and provider of premium body contouring procedures, today announced it will report third quarter 2025 financial results before market open on Friday, November 7, 2025, to be followed by a conference call on the same da...
Themefolio
Profiler
Peergroup
© Globe Newswire
31.10.2025
ISIN: AU000000IMC7
Immuron Limited
IMC
LISTED
ASX
Immuron Announces Clinical Trial Update
News Preview
MELBOURNE, Australia, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated biopharmaceutical company provides a clinical trial update on Travelan® and IMM-529....
Themefolio
Profiler
Peergroup
© Globe Newswire
31.10.2025
ISIN: SE0002190926
Karolinska Development AB
KDEV
LISTED
STO
Karolinska Development’s portfolio company BOOST Pharma presents positive long-term data for its cell-based treatment of Osteogenesis imperfecta
News Preview
STOCKHOLM, SWEDEN, October 31, 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company BOOST Pharma has presented new long-term data from the BOOSTB4 phase 1/2 trial with the company’s cell therapy BT-101 targeting the rare bone disease Osteogenesis imperfecta. The new results comprise two-year follow-up...
Themefolio
Profiler
Peergroup
© PR Newswire
31.10.2025
ISIN: SE0014855029
Implantica AG
IMP A-SDB
LISTED
STO
Implantica publishes Interim Report January - September 2025 (Q3)
News Preview
VADUZ, Liechtenstein, Oct. 31, 2025 /PRNewswire/ --
RefluxStop® Nears FDA Approval - Strong Momentum Toward US Market Entry
Significant events in the third quarter of 2025
Rec...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
